Business Segments · Accelerated amortization

Cardiovascular — Accelerated amortization

Medtronic Cardiovascular — Accelerated amortization decreased by 34.8% to $30.00M in Q1 2026 compared to the prior quarter. This is a positive signal — lower values indicate better performance for this metric.

Analysis

StatementSegment
CategoryRisk
SignalLower is better
VolatilityVolatile
First reportedQ3 2025
Last reportedQ1 2026

How to read this metric

An increase signals potential product obsolescence or a strategic decision to phase out certain technologies.

Detailed definition

This represents the non-cash charge taken when the carrying value of an intangible asset in the cardiovascular segment i...

Peer comparison

Comparable to impairment or accelerated amortization charges in the technology-heavy segments of medical device companies.

Metric ID: mdt_segment_cardiovascular_accelerated_amortization

Historical Data

3 periods
 Q3 '25Q4 '25Q1 '26
Value$45.00M$46.00M$30.00M
QoQ Change+2.2%-34.8%
Range$30.00M$46.00M

Frequently Asked Questions

What is Medtronic's cardiovascular — accelerated amortization?
Medtronic (MDT) reported cardiovascular — accelerated amortization of $30.00M in Q1 2026.
What does cardiovascular — accelerated amortization mean?
An extra, non-cash charge for the faster-than-expected decline in value of cardiovascular intangible assets.